9.66
Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference - The Manila Times
Will Aligos Therapeutics Inc. (5WK0) stock gain from green policiesGap Up & High Accuracy Investment Entry Signals - newser.com
Why Aligos Therapeutics Inc. stock appeals to dividend seekersWeekly Trade Report & Fast Entry Momentum Trade Alerts - newser.com
Why Aligos Therapeutics Inc. stock remains on buy listsWeekly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Is Aligos Therapeutics Inc. stock positioned well for digital economy2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Published on: 2025-10-13 09:41:36 - newser.com
How buybacks impact Aligos Therapeutics Inc. stock valueJuly 2025 Market Mood & High Return Trade Guides - newser.com
Is Aligos Therapeutics Inc. stock supported by strong fundamentalsTrade Risk Assessment & Weekly High Conviction Ideas - newser.com
Risk adjusted return profile for Aligos Therapeutics Inc. analyzedDip Buying & AI Enhanced Trading Alerts - newser.com
Is Aligos Therapeutics Inc. stock ready for a breakoutDip Buying & Intraday High Probability Setup Alerts - newser.com
Using data tools to time your Aligos Therapeutics Inc. exit2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
Why Aligos Therapeutics Inc. is moving todayWeekly Trade Review & AI Enhanced Market Trend Forecasts - newser.com
How Aligos Therapeutics Inc. stock reacts to inflationary pressuresJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Is Aligos Therapeutics Inc. stock bottoming outMarket Sentiment Review & Verified Momentum Watchlists - newser.com
What momentum shifts mean for Aligos Therapeutics Inc.Gold Moves & Real-Time Chart Breakout Alerts - newser.com
Does Aligos Therapeutics Inc. qualify in momentum factor screeningTrade Analysis Report & Community Consensus Trade Signals - newser.com
Aligos Therapeutics (NASDAQ:ALGS) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Published on: 2025-10-08 08:18:12 - earlytimes.in
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025 - Investing News Network
Aligos Therapeutics, Inc. Announces Eight Presentations at The Liver Meeting® 2025, Including Oral Presentation on Novel HBV Therapy - Quiver Quantitative
8 Abstracts Accepted — Aligos Presents Oral 96‑Week ALG-000184 HBV Data at The Liver Meeting 2025 - Stock Titan
Is Aligos Therapeutics Inc 5WK0 a good long term investmentStop Loss Placement Tips & High Profit Stock Alerts - earlytimes.in
Aligos Therapeutics reports new PD-1/PD-L1 interaction inhibitors - BioWorld MedTech
Is Aligos Therapeutics Inc. (5WK0) stock a fit for income portfoliosPortfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com
How Aligos Therapeutics Inc. (5WK0) stock stacks up against competitorsJuly 2025 Final Week & Real-Time Stock Price Movement Reports - newser.com
How strong is Aligos Therapeutics Inc. stock balance sheetWeekly Trend Summary & Smart Money Movement Alerts - newser.com
How Aligos Therapeutics Inc. (5WK0) stock trades in high volatility2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com
Aligos Therapeutics Inc. stock daily chart insightsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
What to do if you’re stuck in Aligos Therapeutics Inc.July 2025 Sector Moves & Fast Gain Stock Tips - newser.com
D pipeline2025 Big Picture & Real-Time Price Movement Reports - newser.com
Aligos Therapeutics (NASDAQ:ALGS) Shares Up 5% – Should You Buy? - Defense World
What drives First Tellurium Corp G1J stock priceTake Profit Strategies & Minimal Capital Trading Tips - earlytimes.in
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):